News & Updates
Filter by Specialty:
Show Multimedia Only
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
byAudrey Abella
In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
Machine learning shows potential in detection of age-related macular degeneration
04 May 2022
Existing machine learning classifiers for age-related macular degeneration (AMD) demonstrate promising diagnostic accuracy, reports a recent meta-analysis.
Machine learning shows potential in detection of age-related macular degeneration
04 May 2022
CYP39A1 G204E variant ups risk of glaucoma, blindness in patients with exfoliation syndrome
18 Apr 2022
Patients with exfoliating syndrome (XFS) who carry the CYP39A1 G204E mutation are at significantly higher risk of blindness, have higher occurrence of exfoliation glaucoma (XFG), and display more severe glaucoma than those with XFS without any CYP39A1 mutation, reveals a study.